MarketFriction

Desh Rakshak Aushdhalaya Ltd

BSE 531521 · Pharmaceuticals
₹26.90 +0.00%
BSE close2026-09-01
Market cap₹15.3 Cr.
P/E27.9

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue from operations0.841.582.491.081.191.884.391.300.951.403.450.83
Operating costs0.521.272.070.810.851.593.431.050.681.142.820.59
EBITDA0.320.310.420.270.340.290.960.250.270.260.630.24
EBITDA margin %38.10%19.62%16.87%25.00%28.57%15.43%21.87%19.23%28.42%18.57%18.26%28.92%
Depreciation & amortisation0.110.110.110.110.110.110.310.100.100.100.130.11
Finance costs0.120.110.070.070.080.080.220.050.080.060.100.05
Non-operating income0.000.040.000.000.000.020.010.000.000.000.010.00
Pre-tax profit0.090.130.240.090.150.120.440.100.090.100.410.08
Effective tax rate %0.00%0.00%33.33%0.00%0.00%0.00%20.45%0.00%0.00%0.00%26.83%0.00%
Profit after tax0.090.130.160.090.150.120.360.100.080.090.300.08
Earnings per share (Rs)0.200.290.360.200.340.270.810.230.140.160.530.14
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue from operations4.985.055.055.515.066.566.146.135.956.187.036.63
Operating costs4.264.394.344.734.275.614.944.744.664.925.515.23
EBITDA0.720.660.710.780.790.951.201.391.291.261.521.40
EBITDA margin %14.46%13.07%14.06%14.16%15.61%14.48%19.54%22.68%21.68%20.39%21.62%21.12%
Depreciation & amortisation0.240.220.240.250.270.260.400.440.440.420.440.44
Finance costs0.110.110.130.130.160.160.240.420.370.310.310.29
Non-operating income0.010.010.010.010.010.020.01-0.050.020.03-0.100.01
Pre-tax profit0.380.340.350.410.370.550.570.480.500.560.670.68
Effective tax rate %23.68%17.65%20.00%19.51%18.92%23.64%15.79%14.58%16.00%16.07%16.42%
Profit after tax0.290.280.280.340.300.420.480.410.430.480.560.55
Earnings per share (Rs)0.650.630.630.770.680.951.080.920.971.080.980.97
Paid out as dividend %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Revenue CAGR4%1%5%-24%
Profit CAGR8%9%12%-25%
Share price CAGR13%%%-57%
Average return on equity5%5%5%6%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Net block (property, plant)3.693.753.873.934.395.386.497.828.077.687.848.20
Capital work in progress1.352.372.372.372.372.372.372.372.372.371.871.39
Investments0.120.120.120.120.120.120.050.050.050.050.050.05
Current & other assets4.423.843.804.384.474.455.665.885.256.228.2211.25
Total assets9.5810.0810.1610.8011.3512.3214.5716.1215.7416.3217.9820.89
Share capital4.664.664.664.664.664.664.664.664.664.664.665.92
Reserves & surplus2.152.462.743.023.453.724.144.624.474.825.297.37
Total debt1.061.470.690.961.232.032.904.314.102.783.042.80
Other liabilities & provisions1.711.492.072.162.011.912.872.532.514.064.994.80
Equity + liabilities9.5810.0810.1610.8011.3512.3214.5716.1215.7416.3217.9820.89
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating cash flow0.271.270.23-0.15-0.550.590.840.230.451.52-0.30-1.31
Investing cash flow-0.45-0.66-0.760.040.42-1.27-1.26-1.95-0.78-0.09-0.02-1.64
Free cash flow (after capex)-0.240.20-0.110.250.07-0.66-0.54-1.51-0.201.47-0.37-2.81
Financing cash flow0.000.000.000.070.000.740.801.350.15-1.340.253.02
Net change in cash-0.180.61-0.53-0.04-0.120.060.37-0.36-0.180.09-0.070.08
Cash conversion (OCF / EBITDA) %42%188%44%-11%-60%84%102%27%37%124%-17%-79%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Return on capital employed %2.56%5.95%5.40%5.74%6.01%5.37%6.42%6.41%7.08%6.83%6.89%7.50%
Receivable days127.42125.33146.72179.25196.08221.45214.77236.00216.74314.70434.10476.63
Inventory days215.33160.82191.55193.41120.33123.2372.16117.52107.5146.0129.2632.36
Payable days247.41195.79242.83257.39219.27249.57270.87315.23301.29584.31726.92522.91
Cash cycle (days)95.3590.3795.44115.2697.1495.1116.0638.2922.96-223.60-263.56-13.92
Working capital days180.0394.55117.81148.89153.02162.30117.40164.07149.45108.58174.82329.17
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoter group %64.28%64.28%64.28%64.28%64.28%64.28%64.28%64.28%50.07%50.03%50.03%50.03%
Retail & others %35.71%35.71%35.71%35.71%35.71%35.71%35.72%35.72%49.93%49.97%49.97%49.98%
Shareholder count2,3552,3532,3522,3512,3492,3452,3532,3472,4292,4112,3932,391

Fundamentals

Market value₹ 15.3 Cr.
Last price₹ 26.9
P/E (trailing)27.9
Book value / share₹ 23.3
Return on capital7.50 %
Return on equity5.59 %
Dividend yield0.00 %
Face value₹ 10.0
Revenue CAGR (TTM)-24%
Profit CAGR (TTM)-25%
Standalone figures.
Valuation
Market capRs 15 Cr
Enterprise valueRs 18 Cr
P/E (TTM)27.87x
Price to book1.15x
Price to sales2.31x
EV / EBITDA12.75x
EV / EBIT18.53x
EV / sales2.71x
Earnings yield3.59%
P/E, 3-year average20.84x
P/B, 3-year average0.94x
P/E, 5-year average14.39x
P/B, 5-year average0.66x
Profitability
Operating margin (excl. other income)21.62%
Operating margin (incl. other income)20.20%
EBITDA margin21.27%
Pre-tax margin10.26%
Net profit margin8.30%
Net margin, latest quarter9.64%
ROE4.82%
ROCE6.74%
ROA2.88%
ROE, 3-year average4.79%
ROCE, 3-year average6.82%
ROA, 3-year average2.79%
ROE, 5-year average4.83%
ROCE, 5-year average6.71%
ROA, 5-year average2.81%
ROIC (approx.)5.09%
Tax rate16.42%
Other income / net worth-0.75%
Growth
Sales growth (latest year)13.75%
Profit growth (latest year)16.67%
Sales CAGR, 3 years4.67%
Sales CAGR, 5 years1.39%
Profit CAGR, 3 years10.95%
Profit CAGR, 5 years5.92%
Sales growth QoQ-75.94%
Profit growth QoQ-73.33%
Sales growth YoY (latest quarter)-36.15%
Profit growth YoY (latest quarter)-20.00%
Per share
EPS (TTM)Rs 0.97
EPS (latest year)Rs 0.98
EPS (latest quarter)Rs 0.14
EPS, 3-year averageRs 1.01
EPS, 5-year averageRs 1.01
Book value per shareRs 23.32
Sales per shareRs 11.63
Cash flow per shareRs -2.30
Efficiency
Asset turnover0.34x
Fixed asset turnover0.86x
Inventory turnover12.80x
Inventory days29 days
Debtor days477 days
Debtors turnover0.77x
Leverage
Total debtRs 3 Cr
Cash and bankRs 0 Cr
Net debtRs 3 Cr
Debt to equity0.21x
Net debt / EBITDA1.88x
Interest coverage3.34x
Owners' fund to total sources63.62%
Debt to assets13.40%
Cash flow
Operating cash flow (latest year)Rs -1 Cr
Investing cash flow (latest year)Rs -2 Cr
Financing cash flow (latest year)Rs 3 Cr
Net change in cash (latest year)Rs 0 Cr
Statement figures
Net sales (TTM)Rs 7 Cr
Net sales (latest year)Rs 7 Cr
Sales (latest quarter)Rs 1 Cr
Operating profit excl. other income (latest year)Rs 2 Cr
Operating profit (latest quarter)Rs 0 Cr
Other income (TTM)Rs -0 Cr
EBITDA (TTM)Rs 1 Cr
PBDT (TTM)Rs 1 Cr
Profit before tax (TTM)Rs 1 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 1 Cr
Net profit (latest year)Rs 1 Cr
Net profit (latest quarter)Rs 0 Cr
Depreciation (TTM)Rs 0 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 3 Cr
Total expenditure (latest year)Rs 6 Cr
Total income (latest year)Rs 7 Cr
Share capitalRs 6 Cr
ReservesRs 7 Cr
Shareholders' fundsRs 13 Cr
Total assetsRs 21 Cr
Net blockRs 8 Cr
Capital work in progressRs 1 Cr
InvestmentsRs 0 Cr
ReceivablesRs 9 Cr
InventoryRs 0 Cr
Other liabilitiesRs 5 Cr
Shares outstanding (crore)0.57
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 27.9 is at the 71th percentile of its own 4.3-year range (median 13.5, low 5.3, high 64.5).
P/B 1.15 is at the 62th percentile (median 0.52).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period531521Nifty 50Difference
1 week-4.1%-2.8% -1.3 pts
1 month+13.9%-6.8% +20.7 pts
3 years+347.6%+14.2% +333.4 pts
5 years+557.7%+27.9% +529.8 pts

Red flags

F-score 4 of 8
explainWeak cash conversion Cash from operations was -6% of net profit over the last 3 years
explainShare dilution Share count up 30% in a year, 30% in three
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹1 Cr -36.2% vs Jun 2025. Net profit ₹0 Cr -20.0%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Sun Pharmaceutical Industries Ltd447,47635.420.5 %
Divis Laboratories Ltd250,36384.022.0 %
Torrent Pharmaceuticals Ltd186,15283.415.2 %
Zydus Lifesciences Ltd119,75024.621.1 %
Cipla Ltd111,43031.115.5 %
Laurus Labs Ltd106,92897.817.8 %
Mankind Pharma Ltd105,12049.313.5 %
Dr Reddys Laboratories Ltd104,49432.413.0 %
Aurobindo Pharma Ltd97,68225.812.9 %
Lupin Ltd93,84015.829.9 %
Glenmark Pharmaceuticals Ltd68,90522.139.8 %
Alkem Laboratories Ltd62,77227.621.2 %
Biocon Ltd61,43984.53.61 %
Abbott India Ltd57,94935.944.8 %
Gland Pharma Ltd49,33343.115.1 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Desh Rakshak Aushdhalaya Ltd?

Desh Rakshak Aushdhalaya Ltd (531521) has a market capitalisation of Rs 15.3 Cr. at the 2026-09-01 close.

What is the P/E ratio of Desh Rakshak Aushdhalaya Ltd?

Desh Rakshak Aushdhalaya Ltd trades at a P/E of 27.9 on trailing twelve-month profit, at the 2026-09-01 close.

What were Desh Rakshak Aushdhalaya Ltd's latest quarterly results?

In the Jun 2026 quarter, Desh Rakshak Aushdhalaya Ltd sales was Rs 1 Cr (-36.2% vs Jun 2025) and net profit was Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03